Atopy | Allergic rhinitis | Mild intermittent asthma
Item
physician diagnosis of atopy (allergic rhinitis or mild intermittent asthma)
boolean
C0392707 (UMLS CUI [1])
C2607914 (UMLS CUI [2])
C1960045 (UMLS CUI [3])
Age
Item
age 18-55 years
boolean
C0001779 (UMLS CUI [1])
Non-smoker
Item
nonsmoker (> 5 years)
boolean
C0337672 (UMLS CUI [1])
FEV1
Item
forced expiratory volume in 1 second (fev1) > 70% of the predicted value
boolean
C0748133 (UMLS CUI [1])
Positive Skin prick test Grass seed mixture | Positive Skin prick test Dermatophagoides pteronyssinus
Item
a positive skin prick test for grass mix or d. pteronyssinus at or within 12 months prior to the screening visit
boolean
C1446409 (UMLS CUI [1,1])
C0430561 (UMLS CUI [1,2])
C0440302 (UMLS CUI [1,3])
C1446409 (UMLS CUI [2,1])
C0430561 (UMLS CUI [2,2])
C1122992 (UMLS CUI [2,3])
Informed Consent
Item
informed consent
boolean
C0021430 (UMLS CUI [1])
Female Pregnancy test negative
Item
females with negative pregnancy test
boolean
C0086287 (UMLS CUI [1,1])
C0427780 (UMLS CUI [1,2])
Respiratory Tract Infections
Item
infections of the respiratory tract within the last month
boolean
C0035243 (UMLS CUI [1])
Disease Affecting research results | Cardiovascular Diseases | Malignant Neoplasms | Liver diseases | Kidney Diseases | Hematological Disease | nervous system disorder | Endocrine System Diseases | Lung diseases | Bronchitis, Chronic | Pulmonary Emphysema | Tuberculosis | Bronchiectasis | Cystic Fibrosis
Item
past or present disease, which as judged by the investigator, may affect the outcome of this study. these diseases include, but are not limited to, cardiovascular disease, malignancy, hepatic disease, renal disease, hematological disease, neurological disease, endocrine disease or pulmonary disease (including but not confined to chronic bronchitis, emphysema, tuberculosis, bronchiectasis or cystic fibrosis).
boolean
C0012634 (UMLS CUI [1,1])
C0392760 (UMLS CUI [1,2])
C0683954 (UMLS CUI [1,3])
C0007222 (UMLS CUI [2])
C0006826 (UMLS CUI [3])
C0023895 (UMLS CUI [4])
C0022658 (UMLS CUI [5])
C0018939 (UMLS CUI [6])
C0027765 (UMLS CUI [7])
C0014130 (UMLS CUI [8])
C0024115 (UMLS CUI [9])
C0008677 (UMLS CUI [10])
C0034067 (UMLS CUI [11])
C0041296 (UMLS CUI [12])
C0006267 (UMLS CUI [13])
C0010674 (UMLS CUI [14])
Signs and Symptoms Hematologic Tests | complete blood count with differential | Blood coagulation | Electrolytes | Finding of liver enzyme levels | Body fluid retention Observation parameter
Item
pathological findings in blood tests (differential blood count, blood clotting, electrolytes, liver enzymes, retention parameters)
boolean
C0037088 (UMLS CUI [1,1])
C0018941 (UMLS CUI [1,2])
C0545131 (UMLS CUI [2])
C0005778 (UMLS CUI [3])
C0013832 (UMLS CUI [4])
C1287351 (UMLS CUI [5])
C0268000 (UMLS CUI [6,1])
C0449381 (UMLS CUI [6,2])
Allergen Immunotherapy
Item
subject is undergoing allergen desensitization therapy
boolean
C0162352 (UMLS CUI [1])
Permanent Pharmaceutical Preparations
Item
permanent medication
boolean
C0013227 (UMLS CUI [1,1])
C0205355 (UMLS CUI [1,2])
systemic steroids | inhaled steroids
Item
systemic or inhaled corticosteroid use within the last month
boolean
C2825233 (UMLS CUI [1])
C2065041 (UMLS CUI [2])
Anti-Inflammatory Agents
Item
anti-inflammatory medication within the last month
boolean
C0003209 (UMLS CUI [1])
Pregnancy
Item
pregnancy
boolean
C0032961 (UMLS CUI [1])
nervous system disorder | Mental disorders | Substance Use Disorders | Compliance behavior Limited
Item
neurological or psychiatric disease or history of drug or alcohol abuse which would interfere with the subject's proper completion of the protocol assignment
boolean
C0027765 (UMLS CUI [1])
C0004936 (UMLS CUI [2])
C0038586 (UMLS CUI [3])
C1321605 (UMLS CUI [4,1])
C0439801 (UMLS CUI [4,2])
Compliance behavior Limited
Item
there is a risk of non-compliance with study procedures
boolean
C1321605 (UMLS CUI [1,1])
C0439801 (UMLS CUI [1,2])
Study Subject Participation Status
Item
participation in a clinical trial 30 days prior to enrolment
boolean
C2348568 (UMLS CUI [1])